September 1, 2012
Expand your knowledge with unparalleled access to new, unpublished data and exclusive case studies from companies of all sizes and perspectives at the most comprehensive event for those directly involved with improving the speed, cost, and quality of developing and manufacturing biotherapeutics.
This event will help you improve manufacturing and development efficiency, enhance process understanding and quality, advance cell culture and upstream processing, streamline recovery and purification, and optimize the quality and novelty of your next-generation biologic drug products. To customize your experience, new programming has been added on antibody–drug conjugates, analytical technologies, quality, engineering, vaccines, biosimiliars, fill and finish, drug product development, viral safety cleaning and cleaning validation, analytical technologies, and formulation and delivery strategies. More than 165 presentations will deliver real-world solutions in all these areas.
Keynotes
“Successfully Partnering Pharmaceutical Manufacturing throughout Product Lifecycle,” by John Stubenrauch (head of external biologics commercialization and operations at Merck & Co., Inc.)
“Targeted Development of a Biosimilar Using Quality by Design Concepts,” by Thomas Stangler (development strategy and technology manager at Sandoz Biopharmaceuticals)
“Regulatory Challenges for Biologics: Biosimilars, Characterization, and QbD,” by Steven Kozlowski (director of FDA/CDER’s Office of Biotechnology Products)
“Driving Value through Biopharmaceutical Manufacturing,” by Jörg Thömmes (vice president of global engineering and facilities at Biogen Idec)
“Improving Access and Affordability to Biopharmaceuticals in the Emerging Markets Through Partnerships,” by Matthew B. Walker (vice president of operations at Pfizer Global Supply)
Featured Presentation
“Regulation of Biosimilars,” by Emily Shacter (consultant with ThinkFDA, LLC and former chief of FDA/CDER’s laboratory of biochemistry)
Program Tracks
Improve Manufacturing and Development Efficiency: Find best practices for flexible facilities, reducing cycle and change-over time and achieving operational excellence. Hear the latest technologies that can drive value.
Product Lifecycle Management: These sessions allow you to understand how industry experts guide product and process changes in the face of pressures to decrease health-care costs with competition from biosimilars and reach the over-arching goal of enhancing process understanding and maintaining or improving product quality.
Advance Cell Culture and Upstream Processing: Improve all aspects of your cell culture process development by learning how to leverage novel technologies and integrate process innovation.
Recovery and Purification: Learn how incorporating new technologies and concepts during harvest, recovery, and purification steps will help you to streamline downstream processing, eliminate bottlenecks, improve time to market, and reduce costs.
Formulation and Delivery Strategies for Protein Therapeutics: Sessions give you a focused examination of the functional steps taken in late-stage development that will result in the next generation of biologic drug products.
New Hot Topics: Optimize antibody–drug conjugate development and production. Discover successful biosimilar development strategies in an evolving regulatory environment. Apply disruptive technologies to streamline recovery and purification. Develop and implement truly continuous drug-substance processes. Learn about major developments for viral safety evaluation of biologics. For vaccine development and production, learn about new technologies, lean operations, single-use systems, and global deployment. Coverage of drug product topics includes risk management, fill–finish operations, and best practices in cleaning and cleaning validation.
Special Colocated Events
An expanded roster of preconference symposia topics includes single-use systems, managing variability in raw materials, CMC project management, and microbial protein production systems. Five two-day training course topics include an introduction to biopharmaceuticals, vaccine manufacturing, cell culture and fermentation bioprocessing, analytical method development, stability, and antibody engineering.
Poster Presentations: Gain recognition from your peers by presenting a scientific poster. Two winners will be published in BioProcess International‘s poster hall supplement.
Thought Leadership Forums: Discuss, debate, and listen to best practices on today’s most pressing issues.
Exhibit Hall: Enjoy over 18 hours of dedicated networking time with industry professionals from around the world. Explore the latest array of technologies and services from >150 exhibitors. Your BPI Conference passport is an interactive venture that leads you to many exhibitors offering exciting prizes. The emerging marketplace in the hall allows you to meet new, young companies that offer novel technologies or services that may be the leaders of the future. Come prepared to talk fast, talk best practices, and make new business connections during two speed-networking sessions (back by popular demand).
The BioProcess InternationalAwards Ceremony Honoring a Decade of BioProcess is your chance to share in the industry’s latest scientific achievements.
BPI Subscribers Save!
IBC has designed three- and four-day conferences package options to fit all your needs. Find complete details online, or call 1-800-309-4078. When registering, please mention this priority code: BPIFESPT and save 20% off the standard rates. This offer is for new registrations only and cannot be combined with other offers.
Testimonials
“This conference is a great place to meet technical experts in the industry. I enjoyed exchanging research ideas with global companies and sparking new collaboration.” —Kelvin Lau, Senior Process Engineer, Abbott
“BPI was great, and I absolutely enjoyed every moment of it.” —Rahul Godawat, Process Scientist, Purification Development, Genzyme Corporation
“This conference is both a great opportunity for ‘newbies’ in the field to get a great perspective as well as for ‘veterans’ to share the latest advances and learnings.” —Elizabeth C. Dodson, Manager R&D, BD Biosciences
“BPI was a great conference. I enjoyed the presentations, discussions, and networking.” —Saeko Tanaka, Director, Cell Line Development, Chugai Pharmaceutical Co., Ltd, Japan
“A key forum for all aspects of biopharmaceutical process development and CMC!” —Dr
. Jens H. Vogel, Global CMC Development Team Leader and Head, Isolation and Purification, Bayer Healthcare
“A great mix of practical and strategic themes; good opportunities for networking with relevant industry players.” —Sancha Salgueiro, Manager, Novozymes
You May Also Like
